Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 1, 2006, Pages 38-46

  Kim, Dong Wook ^a   Huamani, Jessica ^a   Fu, Allie ^a   Hallahan, Dennis E ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Akt; Combined modality therapy; Endothelium; Radiation sensitizer; Vasculature targeted therapy

Indexed keywords

ENZYME KINETICS; IONIZING RADIATION; MOLECULAR DYNAMICS; RADIATION EFFECTS; RADIOTHERAPY;

AKT; COMBINED MODALITY THERAPY; ENDOTHELIUM; RADIATION SENSITIZER; VASCULATURE TARGETED THERAPY;

ONCOLOGY;

2 MORPHOLINO 8 PHENYLCHROMONE; 2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; AP 23573; BEVACIZUMAB; EVEROLIMUS; IC 486068; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONOCLONAL ANTIBODY DC101; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SEMAXANIB; SUNITINIB; TEMSIROLIMUS; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VATALANIB; WORTMANNIN;

CANCER; CANCER RADIOTHERAPY; CELL VIABILITY; CONFERENCE PAPER; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; IONIZING RADIATION; MICROENVIRONMENT; PRIORITY JOURNAL; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOGENESIS INHIBITORS; ANIMALS; COMBINED MODALITY THERAPY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INDOLES; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PYRROLES; QUINAZOLINES; RADIATION TOLERANCE; RECEPTOR PROTEIN-TYROSINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 29244431955     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.02.008     Document Type: Conference Paper

References (68)

1. V.T. De Vita Jr, S. Hellman, S.A. Rosenberg 6th ed. Cancer. Principles and practice of oncology Vol 1 2001 Lippincott Williams & Wilkins Philadelphia
2. Z. Fuks, I. Vlodavsky, M. Andreeff Effects of extracellular matrix on the response of endothelial cells to radiation in vitro Eur J Cancer 28A 1992 725 731
3. M. Garcia-Barros, F. Paris, C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 2003 1155 1159
4. F. Paris, Z. Fuks, A. Kang Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice Science 293 2001 293 297
5. P. Wachsberger, R. Burd, A.P. Dicker Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents Exploring mechanisms of interaction Clin Cancer Res 9 2003 1957 1971
6. P. Wachsberger, R. Burd, A.P. Dicker Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways Hematol Oncol Clin North Am 18 2004 1039 1057 viii
7. H.J. Mauceri, N.N. Hanna, M.A. Beckett Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 1998 287 291
8. D.H. Gorski, M.A. Beckett, N.T. Jaskowiak Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res 59 1999 3374 3378
9. J. Tan, D.E. Hallahan Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response Cancer Res 63 2003 7663 7667
10. E. Edwards, L. Geng, J. Tan Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation Cancer Res 62 2002 4671 4677
11. L. Geng, E. Donnelly, G. McMahon Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 2001 2413 2419
12. L. Geng, J. Tan, E. Himmelfarb A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction Cancer Res 64 2004 4893 4899
13. A.J. Schueneman, E. Himmelfarb, L. Geng SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models Cancer Res 63 2003 4009 4016
14. K. Datta, A. Bellacosa, T.O. Chan Akt is a direct target of the phosphatidylinositol 3-kinase Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells J Biol Chem 271 1996 30835 30839
15. B. Vanhaesebroeck, D.R. Alessi The PI3K-PDK1 connection More than just a road to PKB Biochem J 346 2000 561 576
16. D.R. Alessi, S.R. James, C.P. Downes Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr Biol 7 1997 261 269
17. J.N. Contessa, J. Hampton, G. Lammering Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells Oncogene 21 2002 4032 4041
18. R.C. Stein Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment Endocr Relat Cancer 8 2001 237 248
19. I.D. Hiles, M. Otsu, S. Volinia Phosphatidylinositol 3-kinase Structure and expression of the 110 kd catalytic subunit Cell 70 1992 419 429
20. A. Klippel, J.A. Escobedo, Q. Hu A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo Mol Cell Biol 13 1993 5560 5566
21. A. Klippel, J.A. Escobedo, M. Hirano The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity Mol Cell Biol 14 1994 2675 2685
22. D.F. Stern Tyrosine kinase signalling in breast cancer ErbB family receptor tyrosine kinases Breast Cancer Res 2 2000 176 183
23. R.M. Neve, H. Sutterluty, N. Pullen Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells Oncogene 19 2000 1647 1656
24. N. Altiok, S. Altiok, J.P. Changeux Heregulin-stimulated acetylcholine receptor gene expression in muscle Requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity Embo J 16 1997 717 725
25. J. Downward Lipid-regulated kinases Some common themes at last Science 279 1998 673 674
26. D.R. Alessi, M. Andjelkovic, B. Caudwell Mechanism of activation of protein kinase B by insulin and IGF-1 Embo J 15 1996 6541 6551
27. M.P. Wymann, L. Pirola Structure and function of phosphoinositide 3-kinases Biochim Biophys Acta 1436 1998 127 150
28. I. Vivanco, C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501
29. H. Dudek, S.R. Datta, T.F. Franke Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661 665
30. S.R. Datta, H. Dudek, X. Tao Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241
31. D. Zingg, O. Riesterer, D. Fabbro Differential activation of the phosphatidylinositol 3′-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells Cancer Res 64 2004 5398 5406
32. D.W. Kim, B. Lu, D.E. Hallahan Receptor tyrosine kinase inhibitors as anti-angiogenic agents Curr Opin Investig Drugs 5 2004 597 604
33. M. Prewett, J. Huber, Y. Li Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors Cancer Res 59 1999 5209 5218
34. I.F. Dunn, O. Heese, P.M. Black Growth factors in glioma angiogenesis FGFs, PDGF, EGF, and TGFs J Neurooncol 50 2000 121 137
35. Z. Fuks, R.S. Persaud, A. Alfieri Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo Cancer Res 54 1994 2582 2590
36. G. Seghezzi, S. Patel, C.J. Ren Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries An autocrine mechanism contributing to angiogenesis J Cell Biol 141 1998 1659 1673
37. J.C. Tsai, C.K. Goldman, G.Y. Gillespie Vascular endothelial growth factor in human glioma cell lines Induced secretion by EGF, PDGF-BB, and bFGF J Neurosurg 82 1995 864 873
38. L. Witte, Z. Fuks, A. Haimovitz-Friedman Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells Cancer Res 49 1989 5066 5072
39. J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 103 2000 211 225
40. L. Claesson-Welsh Signal transduction by the PDGF receptors Prog Growth Factor Res 5 1994 37 54
41. L. Claesson-Welsh Platelet-derived growth factor receptor signals J Biol Chem 269 1994 32023 32026
42. D.W. Kim, H. Choy Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 11 20
43. S.V. Kozin, Y. Boucher, D.J. Hicklin Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts Cancer Res 61 2001 39 44
44. A. Abdollahi, K.E. Lipson, X. Han SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro Cancer Res 63 2003 3755 3763
45. M. Bischof, A. Abdollahi, P. Gong Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells Int J Radiat Oncol Biol Phys 60 2004 1220 1232
46. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
47. C.H. Crane, L.M. Ellis, M.S. O'Reilly RhuMab VEGF (Bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer An active, well tolerated regimen Int J Radiat Oncol Biol Phys 60 Suppl. 1 2004 S149
48. J.M. Wood, G. Bold, E. Buchdunger PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res 60 2000 2178 2189
49. C. Hess, V. Vuong, I. Hegyi Effect of VEGF receptor inhibitor PTK787/ZK222584 combined with ionizing radiation on endothelial cells and tumour growth Br J Cancer 85 2001 2010 2016
50. A.D. Laird, J.G. Christensen, G. Li SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice Faseb J 16 2002 681 690
51. A.D. Laird, P. Vajkoczy, L.K. Shawver SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors Cancer Res 60 2000 4152 4160
52. R.J. Griffin, B.W. Williams, R. Wild Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response Cancer Res 62 2002 1702 1706
53. B. Lu, L. Geng, A. Musiek Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium Int J Radiat Oncol Biol Phys 58 2004 844 850
54. D.B. Mendel, A.D. Laird, X. Xin In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors Determination of a pharmacokinetic/pharmacodynamic relationship Clin Cancer Res 9 2003 327 337
55. A.K. Gupta, G.J. Cerniglia, R. Mick Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002 Int J Radiat Oncol Biol Phys 56 2003 846 853
56. J.N. Sarkaria, R.S. Tibbetts, E.C. Busby Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin Cancer Res 58 1998 4375 4382
57. K.E. Rosenzweig, M.B. Youmell, S.T. Palayoor Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay Clin Cancer Res 3 1997 1149 1156
58. B.D. Price, M.B. Youmell The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage Cancer Res 56 1996 246 250
59. Sadhu C, Dick K, Treiberg J. Inhibitors of human phosphatidylinositol 3-kinase delta. US Patent Application 20020161014 2002;WO 01/81346.
60. S. Chan Targeting the mammalian target of rapamycin (mTOR) A new approach to treating cancer Br J Cancer 91 2004 1420 1424
61. T. Boehm, J. Folkman, T. Browder Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
62. W. Arap, R. Pasqualini, E. Ruoslahti Chemotherapy targeted to tumor vasculature Curr Opin Oncol 10 1998 560 565
63. W. Arap, R. Pasqualini, E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380
64. R. Pasqualini, E. Koivunen, E. Ruoslahti Alpha v integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 15 1997 542 546
65. D. Hallahan, L. Geng, S. Qu Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels Cancer Cell 3 2003 63 74
66. D.E. Hallahan, L. Geng, A.J. Cmelak Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature J Control Release 74 2001 183 191
67. K. Camphausen, M.A. Moses, C. Menard Radiation abscopal antitumor effect is mediated through p53 Cancer Res 63 2003 1990 1993
68. L. Geng, K. Osusky, S. Konjeti Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay J Control Release 99 2004 369 381